KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Interest Expenses (2023 - 2025)

Historic Interest Expenses for Fulgent Genetics (FLGT) over the last 3 years, with Q3 2025 value amounting to $28000.0.

  • Fulgent Genetics' Interest Expenses rose 10000.0% to $28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $99000.0, marking a year-over-year increase of 12853.03%. This contributed to the annual value of -$170000.0 for FY2024, which is 13483.61% down from last year.
  • As of Q3 2025, Fulgent Genetics' Interest Expenses stood at $28000.0, which was up 10000.0% from $17000.0 recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Interest Expenses ranged from a high of $70000.0 in Q3 2023 and a low of -$249000.0 during Q1 2024
  • For the 3-year period, Fulgent Genetics' Interest Expenses averaged around -$19777.8, with its median value being $17000.0 (2025).
  • Examining YoY changes over the last 5 years, Fulgent Genetics' Interest Expenses showed a top increase of 12919.71% in 2024 and a maximum decrease of 8000.0% in 2024.
  • Over the past 3 years, Fulgent Genetics' Interest Expenses (Quarter) stood at -$137000.0 in 2023, then skyrocketed by 129.2% to $40000.0 in 2024, then dropped by 30.0% to $28000.0 in 2025.
  • Its Interest Expenses was $28000.0 in Q3 2025, compared to $17000.0 in Q2 2025 and $14000.0 in Q1 2025.